AstraZeneca is acquiring Modella AI to embed multimodal foundation models into oncology R&D and strengthen biomarker driven ...

Lyme disease (LD) is associated with substantial health care costs, with per-patient direct costs consistently high across ...

NVIDIA and Lilly put $1B behind AI as core drug infrastructure During the JPMorgan Healthcare Conference week in mid January ...

NVIDIA and Eli Lilly plan to invest up to $1B over five years in a joint AI lab to tighten the loop between model building ...

1. In diabetes-free individuals with metabolic dysfunction–associated steatotic liver disease (MASLD) and obesity, berberine is safe, well-tolerated, and associated with a significant reduction in low ...

New FDA communication introduces a more flexible, risk‑based chemistry, manufacturing, and controls (CMC) framework for cell and gene therapies, including phased data submission to support earlier ...

Compared to placebo, edaravone dexborneol improved functional independence at 90 days in patients with acute ischaemic stroke who underwent endovascular thrombectomy. Evidence Rating Level: 1 ...

Ethosuximide was not superior to placebo for the treatment of abdominal pain in adults with irritable bowel syndrome. Evidence Rating Level: 1 (Excellent) Previous research suggested that increased ...